Newly Diagnosed Multiple Myeloma Recruiting Phase 2 Trials for Isatuximab (DB14811)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04891809Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMMTreatment